EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance

Sophie Charlotte Steinbuch, Anne-Marie Lüß, Stephanie Eltrop, Martin Götte iD, Ludwig Kiesel

International Journal of Molecular Sciences · 13.04.2024 · 25 (8) · 4306

DOI: 10.3390/ijms25084306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.04.2024. Verfasst von Sophie Charlotte Steinbuch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Münster University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic condition affecting reproductive-aged women, characterized by the growth of ectopic endometrial tissue. Despite being benign, endometriosis is associated with an increased risk of certain cancers, including endometriosis-associated ovarian cancer (EAOC). Ovarian cancer is rare, but more common in women with endometriosis, particularly endometrioid and clear-cell carcinomas. Factors such as hormonal imbalance, reproductive history, environmental exposures, and genetic predisposition contribute to the malignant transformation of endometriosis. Thus, understanding potential risk factors causing malignancy is crucial. Over the past few decades, various genetic mutations, microRNAs, as well as tumor microenvironmental factors have been identified, impacting pathways like PI3K/AKT/mTOR, DNA repair mechanisms, oxidative stress, and inflammation. Thus, this review aims to summarize molecular studies involved in EAOC pathogenesis as potential therapeutic targets. However, further research is needed to better understand the molecular and environmental factors driving EAOC development, to target the susceptibility of endometriotic lesions to malignant progression, and to identify effective therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisOvarian NeoplasmsHumansFemaleTumor MicroenvironmentMicroRNAsGenetic Predisposition to DiseaseSignal TransductionClinical Relevance

Stichwörter der Autor:innen

EAOCendometriosisovarian cancer

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.
  • Cells-in-Motion Interfaculty Centre (CiMIC), University of Münster, 48149 Münster, Germany.

ORCID-Profile: Martin Götte

Förderung

  • Münster University

Zitieren

APA

Steinbuch, S. C., Lüß, A. M., Eltrop, S., Götte, M., & Kiesel, L. (2024). Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance. International Journal of Molecular Sciences, 25(8), 4306. https://doi.org/10.3390/ijms25084306

Vancouver

Steinbuch SC, Lüß AM, Eltrop S, Götte M, Kiesel L. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance. International Journal of Molecular Sciences. 2024;25(8):4306. doi:10.3390/ijms25084306

BibTeX
@article{Steinbuch2024,
  author = {Steinbuch, Sophie Charlotte and Lüß, Anne-Marie and Eltrop, Stephanie and Götte, Martin and Kiesel, Ludwig},
  title = {Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {8},
  pages = {4306},
  doi = {10.3390/ijms25084306}
}
Kostenlos starten →